WAVE LIFE SCIENCES LTD's ticker is WVE and the CUSIP is Y95308105. A total of 144 filers reported holding WAVE LIFE SCIENCES LTD in Q2 2024. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $33,626,286 | -14.5% | 6,738,735 | +5.7% | 0.00% | 0.0% |
| Q1 2024 | $39,335,294 | +45.2% | 6,375,250 | +18.8% | 0.00% | 0.0% |
| Q4 2023 | $27,099,753 | -3.1% | 5,366,288 | +10.3% | 0.00% | 0.0% |
| Q3 2023 | $27,966,654 | +66.1% | 4,863,766 | +5.2% | 0.00% | – |
| Q2 2023 | $16,833,744 | +175.5% | 4,624,655 | +227.8% | 0.00% | – |
| Q1 2023 | $6,109,297 | -41.2% | 1,410,923 | -4.9% | 0.00% | – |
| Q4 2022 | $10,381,329 | +111.5% | 1,483,047 | +9.1% | 0.00% | – |
| Q3 2022 | $4,909,000 | +13.1% | 1,359,873 | +1.8% | 0.00% | – |
| Q2 2022 | $4,341,000 | -26.1% | 1,335,487 | -54.5% | 0.00% | – |
| Q1 2022 | $5,876,000 | -35.3% | 2,937,786 | +1.5% | 0.00% | – |
| Q4 2021 | $9,086,000 | -34.7% | 2,894,363 | +2.0% | 0.00% | – |
| Q3 2021 | $13,905,000 | -26.5% | 2,837,787 | -0.1% | 0.00% | -100.0% |
| Q2 2021 | $18,911,000 | +13.0% | 2,839,335 | -4.8% | 0.00% | – |
| Q1 2021 | $16,739,000 | -29.7% | 2,983,535 | -1.4% | 0.00% | -100.0% |
| Q4 2020 | $23,808,000 | +14.2% | 3,025,204 | +23.2% | 0.00% | 0.0% |
| Q3 2020 | $20,839,000 | -13.1% | 2,454,738 | +6.6% | 0.00% | 0.0% |
| Q2 2020 | $23,981,000 | +41.0% | 2,303,686 | +26.9% | 0.00% | 0.0% |
| Q1 2020 | $17,007,000 | +15.9% | 1,814,881 | -0.9% | 0.00% | 0.0% |
| Q4 2019 | $14,672,000 | -61.1% | 1,830,620 | -0.3% | 0.00% | -50.0% |
| Q3 2019 | $37,689,000 | -20.3% | 1,835,796 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $47,275,000 | -28.4% | 1,811,996 | +6.7% | 0.00% | -33.3% |
| Q1 2019 | $65,995,000 | +1.1% | 1,698,704 | +9.4% | 0.00% | 0.0% |
| Q4 2018 | $65,273,000 | +7.5% | 1,552,595 | +27.8% | 0.00% | 0.0% |
| Q3 2018 | $60,742,000 | +32.2% | 1,214,843 | +1.1% | 0.00% | +50.0% |
| Q2 2018 | $45,963,000 | +30.7% | 1,201,655 | +37.0% | 0.00% | 0.0% |
| Q1 2018 | $35,167,000 | +7.2% | 876,996 | -6.2% | 0.00% | 0.0% |
| Q4 2017 | $32,810,000 | +158.2% | 934,733 | +60.0% | 0.00% | +100.0% |
| Q3 2017 | $12,706,000 | +24.7% | 584,163 | +6.6% | 0.00% | 0.0% |
| Q2 2017 | $10,189,000 | +10.2% | 547,827 | +62.9% | 0.00% | 0.0% |
| Q1 2017 | $9,249,000 | +92390.0% | 336,365 | +90078.3% | 0.00% | – |
| Q4 2016 | $10,000 | -16.7% | 373 | 0.0% | 0.00% | – |
| Q3 2016 | $12,000 | -47.8% | 373 | -66.8% | 0.00% | – |
| Q2 2016 | $23,000 | – | 1,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,512,049 | $287,336,000 | 18.66% |
| BERYLSON CAPITAL PARTNERS, LLC | 162,238 | $6,206,000 | 7.67% |
| Boxer Capital, LLC | 1,590,600 | $60,840,000 | 6.89% |
| New Leaf Venture Partners, L.L.C. | 433,429 | $16,579,000 | 4.00% |
| Redmile Group, LLC | 2,244,507 | $85,852,000 | 2.92% |
| EMORY UNIVERSITY | 67,925 | $2,598,000 | 1.72% |
| EcoR1 Capital, LLC | 412,871 | $15,792,000 | 1.50% |
| BB BIOTECH AG | 1,137,885 | $43,524,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 562,615 | $21,520,000 | 1.17% |
| Matisse Capital | 37,234 | $1,424,000 | 1.13% |